HAEMONETICS CORP stock forecast: up to 77.54 USD HAE stock price prognosis

STOCK

Forecast for Fri 19 May 2023 price 77.54

HAEMONETICS CORP stock price forecast for further price development up to 0.16% (time horizon: 1 day) and price target of 77.54 USD. Short-term (time horizon: 2 weeks) HAEMONETICS CORP share price prediction for 2023-05-19 with daily closed price projections

Key Facts

Symbol HAE 

ISIN US4050241003 

CUSIP 405024100

Currency USD

Category Surgical & Medical Instruments & Apparatus

Forecast price change %

Finance numbers

Revenue 870,463,000.0

Earnings per share 1.55

twitter facebook

On our site we made daily predictions for finance products based on statistical analysis. You can export / download forecasted data as CSV file, no login required. The information can be used for day trading.

Summerized Form 10-K with GPT-2

When used in this report, the terms "we," "us," "our" and "the Company" mean Haemonetics. Blood is essential to a modern healthcare system. There are three primary ways to collect plasma. The NexSys PCS capabilities enable collections with higher plasma yields. Devices deemed by the FDA to pose the greatest risk are placed in Class III. The requirements and process governing product licensing vary from country to country. As a Company, we are also committed to making our workplaces safe and secure. This section contains forward-looking statements. However, there are no guarantees that failures will not occur. The Capped Call Transactions may affect the value of the 2026 Notes and our common stock. International revenues and expenses account for a substantial portion of our operations.

Summerized Form 10-K with GPT-2 https://www.sec.gov/Archives/edgar/data/313143/000031314321000023/0000313143-21-000023.txt
Candlestick patterns

Candlestick patterns can be used as additional information for price prediction. Following list show which pattern applies on latest price information.

  • Meta analyst score 60.76/100
    • Not in ideal financial position.
    • Historical view, profit is growing.
    • Company revenue is growing faster compared with the industry.
    • Stock price is above book price value.

Institutional ownership list is based on filling form information

Holding name Date Amount
A - VOYA INVESTMENT MANAGEMENT LLC 2022-09-30 19864
FIRST HAWAIIAN BANK 2022-09-30 3909
Versant Capital Management, Inc 2022-09-30 9
MASSMUTUAL TRUST CO FSB/ADV 2022-12-31 12
YOUSIF CAPITAL MANAGEMENT, LLC 2022-12-31 26115

Fund ownership list is based on filling form information

Fund name Date Amount Profile
SPDR SERIES TRUST 2022-12-31 186 Long
SPDR SERIES TRUST 2022-12-31 71014 Long
STATE STREET VARIABLE INSURANCE SERIES FUNDS INC 2022-12-31 1458 Long
SPDR SERIES TRUST 2022-12-31 163 Long
SPDR SERIES TRUST 2022-12-31 7685 Long

Insider trading for HAEMONETICS CORP

CIK Name Date Action T-Test 1day T-Test 7day T-Test 14day T-Test 30day
1722327 Goldstein Dan 2022-06-13 SALE Accept Accept Accept Accept
1259254 Kroll Mark W 2022-08-15 SALE Accept Accept Accept Accept
1699629 Basil Michelle L 2022-09-19 SALE Accept Accept Accept Accept
1750812 Llorens Josep 2022-05-19 SALE Accept Accept Accept Accept
1674993 Simon, Christopher 2022-06-13 SALE Accept Accept Accept Accept
1808414 Lingamneni Anila 2022-05-19 SALE Accept Accept Accept Accept
1420910 Strong Stewart W 2022-05-19 SALE Accept Accept Accept Accept
1881751 Miller Laurie A. 2022-09-19 SALE Accept Accept Accept Accept
Assets / Liabilities

Bollinger Bollinger Bands for HAEMONETICS CORP can provide the information where the market is moving based on price information.

HAEMONETICS CORP Short Volume Ratio is shown in the diagram. Short volume sales can be seen as an investor sentiment.

Converting prices to returns HAEMONETICS CORP.

On-Balance Volume information for HAEMONETICS CORP. On-Balance Volume information can be an indicator for bullish or bearish outcome.

Accumulation / Distribution (A/D) indicator information for HAEMONETICS CORP. The indicator identify divergences between price and volume flow.

Aroon Oscillator information for HAEMONETICS CORP. The trend-following indicator can show the strengh of a current trend and likelihood that trend can continue.

Average Directional Index (ADX) information for HAEMONETICS CORP. The index can be used to identify the strengh of a trend.

Moving Average Convergence Divergence (MACD) for HAEMONETICS CORP. The indicator helps to predict trend direction and the momentum of the trend.

Stochastic Oscillator as momentum indicator for HAEMONETICS CORP. The indicator is useful for identifying overbought and oversold levels.

Relative Strength Index (RSI) for HAEMONETICS CORP. RSI is a momentum oscillator that measures the speed and change of price development. The momentum indicator was created by analyst Welles Wilder. The result compares recent gains and losses over restricted time period. Primary usage of the indicator is to identify overbought or oversold signals. When RSI indicator reaches a value of 70 it could mean that speculators should consider selling, suggests Wilder and Chong. Or vice versa when selling excess at which the RSI Indicators show a value of 30 [ Relative Strength Index for Developing Effective Trading Strategies in Constructing Optimal Portfolio ].

52W High 52W Low Market Cap

Similar shares

Trend:
chart
VAPOTHERM INC

Trend:
chart
INOVIO PHARMACEUTICALS INC

Trend:
chart
PLUS THERAPEUTICS INC

Trend:
chart
T2 BIOSYSTEMS INC

News sentiment

HAEMONETICS CORP on Nasdaq

HAEMONETICS CORP on finviz

Figure below show the stock predictions.
Date Closing price Prediction was updated
2023-04-27 77.54 2023-03-25 03:49
2023-04-28 77.56 2023-03-25 03:49
2023-05-01 77.53 2023-03-25 03:49
2023-05-02 77.55 2023-03-25 03:49
2023-05-08 77.54 2023-03-25 03:49
2023-05-09 77.54 2023-03-25 03:49
2023-05-10 77.54 2023-03-25 03:49
2023-05-03 77.55 2023-03-25 03:49
2023-05-04 77.53 2023-03-25 03:49
2023-05-05 77.55 2023-03-25 03:49
2023-05-11 77.54 2023-03-25 03:49
2023-05-12 77.55 2023-03-25 03:49
2023-05-15 77.55 2023-03-25 03:49
2023-05-16 77.54 2023-03-25 03:49
2023-05-17 77.54 2023-03-25 03:49
2023-05-18 77.54 2023-03-25 03:49
2023-05-19 77.54 2023-03-25 03:49
2023-03-29 77.48 2023-03-25 03:49
2023-03-30 77.51 2023-03-25 03:49
2023-03-31 77.50 2023-03-25 03:49
2023-04-03 77.50 2023-03-25 03:49
2023-04-04 77.65 2023-03-25 03:49
2023-04-05 77.48 2023-03-25 03:49
2023-04-10 77.49 2023-03-25 03:49
2023-04-11 77.57 2023-03-25 03:49
2023-04-13 77.62 2023-03-25 03:49
2023-04-06 77.51 2023-03-25 03:49
2023-04-07 77.67 2023-03-25 03:49
2023-04-12 77.53 2023-03-25 03:49
2023-04-14 77.57 2023-03-25 03:49
2023-04-17 77.39 2023-03-25 03:49
2023-04-18 77.50 2023-03-25 03:49
2023-04-19 77.61 2023-03-25 03:49
2023-04-20 77.55 2023-03-25 03:49
2023-04-21 77.53 2023-03-25 03:49
2023-04-24 77.55 2023-03-25 03:49
2023-04-25 77.55 2023-03-25 03:49
2023-04-26 77.54 2023-03-25 03:49

The forecast (dashed curve) of the share price performance is based on historical data. Our forecast model is based on mathematical, statistical methods. The website offers price forecasts and analysis tools for equities and other securities, which are exclusively based on the prices of these securities in the past. Information about these prices is provided to us by third parties. Although we believe, If we believe that our sources are reliable, we cannot guarantee the accuracy, completeness, timeliness and correct sequencing of this information. We do not investigate the issuers of the securities to which our forecasts relate, nor do we consider any financial data or other data of such issuers with the exception of the past prices of the securities. Therefore, our forecasts do not constitute an analysis of other commercial or financial factors or circumstances, that may be relevant for future security price flows. Investments require additional considerations. Our forecasts cannot reflect the specific situation. Experience and risk profile of an individual investor or the tax implications an investment may have for the investor. Although we believe that our mathematical models are a tool to try to explore the possibility for future price development with the help of past performance, such developments are subject to a multitude of different influences. and therefore not really predictable. We cannot guarantee the success of any investment you make based on the information published here. This website is for information purposes only. All information and data on this website cannot be guaranteed to be accurate, accuracy, completeness and appropriateness - neither explicit nor implicit.